Physician profile
James B Flickinger
NPI 1184636284
$22,176.12
in general payments reported to CMS, 2019-2025
19 companies · $5,245 in 2025
The $5,245 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $921 · 2020: $3,203 · 2021: $825 · 2022: $3,392 · 2023: $3,748 · 2024: $4,843 · 2025: $5,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Grant: $3,500 · Food and Beverage: $3,213 · Travel and Lodging: $1,373 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Grant | $3,500.00 |
| Food and Beverage | $3,213.05 |
| Travel and Lodging | $1,372.95 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,779.97 | 2023-2025 | |
| Glaukos Corporation | $4,537.64 | 2023-2025 | Kxl System (Not Refurbished), Travoprost Intraocular Implant - Idose, Kxl System |
| Allergan, INC. | $3,723.99 | 2019-2022 | |
| Coopervision INC. | $3,086.83 | 2019-2023 | Myday Contact Lens |
| Biotissue Holdings INC. | $1,969.91 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $965.87 | 2022-2025 | Miebo, Xiidra, Infuse |
| Alcon Vision LLC | $904.19 | 2019-2025 | Total30, Dailies Total1, Precision7 |
| Sun Pharmaceutical Industries INC. | $478.50 | 2022-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $299.13 | 2019-2022 | |
| Oyster Point Pharma, INC. | $283.15 | 2022-2025 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $256.12 | 2022 | |
| Lkc Technologies, INC. | $217.39 | 2024-2025 | |
| Ocular Therapeutix, INC. | $185.60 | 2022-2024 | Dextenza |
| Tarsus Pharmaceuticals, INC. | $143.81 | 2024-2025 | Xdemvy |
| Topcon Healthcare, INC. | $135.61 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $121.97 | 2019 | |
| Dompe US, INC. | $56.19 | 2023 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $16.85 | 2025 | Tecnis Iol, Tecnis Iol |
| Tearlab Corp | $13.40 | 2023 | Tearlab Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Flickinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.